Kawaguchi Makiko, Banno Kouji, Yanokura Megumi, Kobayashi Yusuke, Kishimi Arisa, Ogawa Seiji, Kisu Iori, Nomura Hiroyuki, Hirasawa Akira, Susumu Nobuyuki, Aoki Daisuke
Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Int J Oncol. 2009 Nov;35(5):977-82. doi: 10.3892/ijo_00000411.
Microsatellite instability (MSI) is an indicator of DNA instability and is caused by abnormalities in DNA mismatch repair (MMR) genes such as hMLH1, hMSH2 and hMSH6. MSI occurs frequently in endometrial cancer (in approximately 30% of cases), and accumulation of gene mutations due to MSI may therefore have a major role in the mechanism of malignant transformation. However, a responsible target gene has not been identified in endometrial cancer. In this study, we analyzed mutations in 11 cancer-related genes with mononucleotide repeats susceptible to MSI in a coding region [hMSH3 (A8), hMSH6 (C8), TGF-beta RII (A10), MBD4 (A10), BAX (G8), PTEN (A6 in exon 7), HDAC2 (A9), EPHB2 (A9), Caspase-5 (A10), TCF-4 (A9) and Axin2 (G7)] in 22 patients with MSI-H sporadic endometrial cancer. Mutations in hMSH6 (C8) and TGF-beta RII (A10) were found most frequently, at rates of 36.3% (8/22) each. Mutations of BAX (G8) and TCF-4 (A9), which are common in MSI-positive colorectal cancer, occurred at rates of 22.7 and 0%, respectively, which suggests that the MSI target gene may differ between endometrial and colorectal cancers. Mutations in hMSH6 (C8) were correlated with reduced protein expression (p=0.042) and patients with these mutations had significantly more mutations in mononucleotide repeats in other cancer-related genes compared to patients without hMSH6 (C8) mutations (p=0.042). This suggests the possibility of a novel cascade in carcinogenesis of endometrial cancer in which MSI mutates hMSH6 (C8), increases gene instability, and leads to accumulation of mutations in other cancer-related genes. To our knowledge, this is the first report to show that hMSH6 (C8) has an important role as an MSI target gene in sporadic endometrial cancer.
微卫星不稳定性(MSI)是DNA不稳定性的一个指标,由DNA错配修复(MMR)基因(如hMLH1、hMSH2和hMSH6)异常引起。MSI在子宫内膜癌中频繁发生(约30%的病例),因此,MSI导致的基因突变积累可能在恶性转化机制中起主要作用。然而,在子宫内膜癌中尚未鉴定出相关的靶基因。在本研究中,我们分析了22例MSI-H散发性子宫内膜癌患者中11个癌症相关基因的突变情况,这些基因在编码区具有易受MSI影响的单核苷酸重复序列[hMSH3(A8)、hMSH6(C8)、转化生长因子-β受体II(TGF-β RII,A10)、MBD4(A10)、BAX(G8)、磷酸酶和张力蛋白同源物(PTEN,第7外显子中的A6)、组蛋白去乙酰化酶2(HDAC2,A9)、 Ephrin B2受体(EPHB2,A9)、半胱天冬酶-5(Caspase-5,A10)、转录因子4(TCF-4,A9)和轴抑制蛋白2(Axin2,G7)]。hMSH6(C8)和TGF-β RII(A10)的突变最为常见,发生率均为36.3%(8/22)。在MSI阳性的结直肠癌中常见的BAX(G8)和TCF-4(A9)突变发生率分别为22.7%和0%,这表明子宫内膜癌和结直肠癌的MSI靶基因可能不同。hMSH6(C8)突变与蛋白表达降低相关(p=0.042),与无hMSH6(C8)突变的患者相比,有这些突变的患者在其他癌症相关基因的单核苷酸重复序列中的突变明显更多(p=0.042)。这提示了子宫内膜癌致癌过程中可能存在一种新的级联反应,即MSI使hMSH6(C8)发生突变,增加基因不稳定性,并导致其他癌症相关基因的突变积累。据我们所知,这是首次报道hMSH6(C8)在散发性子宫内膜癌中作为MSI靶基因发挥重要作用。